| PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy U Haberkorn, LG Strauss, A Dimitrakopoulou, R Engenhart, F Oberdorfer, ... Journal of Nuclear Medicine 32 (8), 1485-1490, 1991 | 356 | 1991 |
| Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. U Haberkorn, LG Strauss, CH Reisser, D Haag, A Dimitrakopoulou, ... Journal of nuclear medicine: official publication, Society of Nuclear …, 1991 | 316 | 1991 |
| Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas MHM Schwarzbach, A Dimitrakopoulou-Strauss, F Willeke, U Hinz, ... Annals of surgery 231 (3), 380, 2000 | 230 | 2000 |
| Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas M Henze, A Dimitrakopoulou-Strauss, S Milker-Zabel, J Schuhmacher, ... Journal of Nuclear Medicine 46 (5), 763-769, 2005 | 198 | 2005 |
| Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy U Haberkorn, LG Strauss, A Dimitrakopoulou, E Seiffert, F Oberdorfer, ... Journal of Nuclear Medicine 34 (1), 12-17, 1993 | 195 | 1993 |
| SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors C Kratochwil, M Stefanova, E Mavriopoulou, T Holland-Letz, ... Molecular Imaging and Biology 17, 313-318, 2015 | 191 | 2015 |
| Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy S Koukouraki, LG Strauss, V Georgoulias, M Eisenhut, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 33, 1115-1122, 2006 | 176 | 2006 |
| The role of quantitative 18F-FDG PET studies for the differentiation of malignant and benign bone lesions A Dimitrakopoulou-Strauss, LG Strauss, T Heichel, H Wu, C Burger, ... Journal of Nuclear Medicine 43 (4), 510-518, 2002 | 174 | 2002 |
| Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F] fluoro-L-dopa with 18F-FDG and 15O-water using compartment and noncompartment analysis A Dimitrakopoulou-Strauss, LG Strauss, C Burger Journal of Nuclear Medicine 42 (2), 248-256, 2001 | 171 | 2001 |
| Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading A Dimitrakopoulou-Strauss, LG Strauss, M Schwarzbach, C Burger, ... Journal of Nuclear Medicine 42 (5), 713-720, 2001 | 170 | 2001 |
| Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab H Anwar, C Sachpekidis, J Winkler, A Kopp-Schneider, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 45, 376-383, 2018 | 167 | 2018 |
| Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy S Koukouraki, LG Strauss, V Georgoulias, J Schuhmacher, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 33, 460-466, 2006 | 158 | 2006 |
| Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI … MT Freitag, JP Radtke, A Afshar-Oromieh, MC Roethke, BA Hadaschik, ... European journal of nuclear medicine and molecular imaging 44, 776-787, 2017 | 147 | 2017 |
| 68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG A Dimitrakopoulou-Strauss, P Hohenberger, U Haberkorn, HR Mäcke, ... Journal of Nuclear Medicine 48 (8), 1245-1250, 2007 | 132 | 2007 |
| 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease E Zamagni, C Nanni, F Gay, A Pezzi, F Patriarca, M Bellò, I Rambaldi, ... Leukemia 30 (2), 417-422, 2016 | 131 | 2016 |
| Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study C Sachpekidis, L Larribere, L Pan, U Haberkorn, ... European journal of nuclear medicine and molecular imaging 42, 386-396, 2015 | 130 | 2015 |
| Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas MHM Schwarzbach, U Hinz, A Dimitrakopoulou-Strauss, F Willeke, ... Annals of surgery 241 (2), 286, 2005 | 121 | 2005 |
| Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas A Dimitrakopoulou-Strauss, LG Strauss, H Goldschmidt, WJ Lorenz, ... European journal of nuclear medicine 22, 434-442, 1995 | 119 | 1995 |
| Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy A Dimitrakopoulou-Strauss, LG Strauss, C Burger, A Rühl, G Irngartinger, ... Journal of Nuclear Medicine 45 (9), 1480-1487, 2004 | 116 | 2004 |
| Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience P Ströbel, R Bargou, A Wolff, D Spitzer, C Manegold, ... British journal of cancer 103 (2), 196-200, 2010 | 113 | 2010 |
Ludwig G. StraussGerman Cancer Research CenterVerified email at ads-lgs.de
